AAAAAA
Results: 1-25/41
Authors:
ADAMS KF
Citation: Kf. Adams, CLINICAL-PRACTICE GUIDELINES FOR HEART-FAILURE, American journal of managed care, 4(6), 1998, pp. 329-334
Authors:
YOUNG JB
GHEORGHIADE M
URETSKY BF
PATTERSON JH
ADAMS KF
Citation: Jb. Young et al., SUPERIORITY OF TRIPLE-DRUG THERAPY IN HEART-FAILURE - INSIGHTS FROM THE PROVED AND RADIANCE TRIALS, Journal of the American College of Cardiology, 32(3), 1998, pp. 686-692
Authors:
WILLIAMSON KM
PATTERSON JH
MCQUEEN RH
ADAMS KF
PIEPER JA
Citation: Km. Williamson et al., EFFECTS OF ERYTHROMYCIN OR RIFAMPIN ON LOSARTAN PHARMACOKINETICS IN HEALTHY-VOLUNTEERS, Clinical pharmacology and therapeutics, 63(3), 1998, pp. 316-323
Authors:
AHMED S
DUNLAP SH
SUETA CA
SCHWARTZ T
TOMASKO L
ROBERTS HV
ADAMS KF
Citation: S. Ahmed et al., DIFFERENCES IN LEFT-VENTRICULAR VOLUME IN AFRICAN-AMERICANS AND CAUCASIANS WITH HEART-FAILURE, Circulation, 98(17), 1998, pp. 1068-1068
Authors:
ADAMS KF
AHMED S
SCHWARTZ T
WEBSTER K
ISLAM T
GHALI JK
Citation: Kf. Adams et al., CURRENT SMOKING IS A PREDICTOR OF MORBIDITY AND MORTALITY IN PATIENTSWITH LEFT-VENTRICULAR DYSFUNCTION, Circulation, 98(17), 1998, pp. 1164-1164
Authors:
ADAMS KF
Citation: Kf. Adams, POST HOC SUBGROUP ANALYSIS AND THE TRUTH OF A CLINICAL-TRIAL, The American heart journal, 136(5), 1998, pp. 753-758
Authors:
ADAMS KF
ZANNAD F
Citation: Kf. Adams et F. Zannad, CLINICAL DEFINITION AND EPIDEMIOLOGY OF ADVANCED HEART-FAILURE, The American heart journal, 135(6), 1998, pp. 204-215
Authors:
ADAMS KF
GHEORGHIADE M
URETSKY BF
YOUNG JB
PATTERSON JH
TOMASKO L
PACKER M
Citation: Kf. Adams et al., CLINICAL PREDICTORS OF WORSENING HEART-FAILURE DURING WITHDRAWAL FROMDIGOXIN THERAPY, The American heart journal, 135(3), 1998, pp. 389-397
Authors:
ADAMS KF
ELLIS ML
WILLIAMSON KM
PATTERSON JH
Citation: Kf. Adams et al., THE AHCPR CLINICAL-PRACTICE GUIDELINE FOR HEART-FAILURE REVISITED, The Annals of pharmacotherapy, 31(10), 1997, pp. 1197-1204
Authors:
ADAMS KF
GHEORGHIADE M
URETSKY BF
YOUNG JB
AHMED S
TOMASKO L
PACKER M
Citation: Kf. Adams et al., PATIENTS WITH MILD HEART-FAILURE WORSEN DURING WITHDRAWAL FROM DIGOXIN THERAPY, Journal of the American College of Cardiology, 30(1), 1997, pp. 42-48
Authors:
DUNLAP SH
ADAMS KF
Citation: Sh. Dunlap et Kf. Adams, OBESITY IN HYPERTENSIVE AFRICAN-AMERICANS PREDICTS DEVELOPMENT OF LEFT-VENTRICULAR SYSTOLIC DYSFUNCTION, Journal of the American College of Cardiology, 29(2), 1997, pp. 30155-30155
Authors:
WILLIAMSON KM
PATTERSON JH
PIEPER JA
MCQUEEN RH
ADAMS KF
Citation: Km. Williamson et al., EFFECTS OF ERYTHROMYCIN OR RIFAMPIN ON STEADY-STATE LOSARTAN PHARMACOKINETICS IN HEALTHY-VOLUNTEERS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 31-31
Authors:
GHALI JK
NICKLAS JM
QUINONES MA
BENEDICT CR
ADAMS KF
GREENBERG BH
KONSTAM MA
WEINER D
FRANCIS GS
Citation: Jk. Ghali et al., PROGNOSTIC VALUE OF ATRIAL-NATRIURETIC-PEPTIDE IN PATIENTS WITH HEART-FAILURE, Circulation, 96(8), 1997, pp. 1475-1475
Authors:
ROSENBERG BS
GREEN H
SCHACHAT F
CHARLES HC
ADAMS KF
HAWTHORNE MH
DUSCHA BD
SLONIGER M
SULLIVAN MJ
Citation: Bs. Rosenberg et al., NORMAL SKELETAL-MUSCLE CONTRACTILE FUNCTION IN PATIENTS WITH CHRONIC HEART-FAILURE, Circulation, 96(8), 1997, pp. 1785-1785
Authors:
DUNLAP SH
SUETA CA
AHMED S
SCHWARTZ T
ROBERTS HV
ADAMS KF
Citation: Sh. Dunlap et al., RISK OF SYSTOLIC DYSFUNCTION IS GREATER IN AFRICAN-AMERICANS WITH HYPERTENSION ASSOCIATED HEART-FAILURE, Circulation, 96(8), 1997, pp. 3354-3354
Authors:
CALIFF RM
ADAMS KF
MCKENNA WJ
GHEORGHIADE M
URETSKY BF
MCNULTY SE
DARIUS H
SCHULMAN K
ZANNAD F
HANDBERGTHURMOND E
HARRELL FE
WHEELER W
SOLERSOLER J
SWEDBERG K
Citation: Rm. Califf et al., A RANDOMIZED CONTROLLED TRIAL OF EPOPROSTENOL THERAPY FOR SEVERE CONGESTIVE-HEART-FAILURE - THE FLOLAN INTERNATIONAL RANDOMIZED SURVIVAL TRIAL (FIRST), The American heart journal, 134(1), 1997, pp. 44-54
Authors:
ADAMS KF
DUNLAP SH
SUETA CA
CLARKE SW
PATTERSON JH
BLAUWET MB
JENSEN LR
TOMASKO L
KOCH G
Citation: Kf. Adams et al., RELATION BETWEEN GENDER, ETIOLOGY AND SURVIVAL IN PATIENTS WITH SYMPTOMATIC HEART-FAILURE, Journal of the American College of Cardiology, 28(7), 1996, pp. 1781-1788
Authors:
PATTERSON JH
ADAMS KF
Citation: Jh. Patterson et Kf. Adams, PATHOPHYSIOLOGY OF HEART-FAILURE - CHANGING PERCEPTIONS, Pharmacotherapy, 16(2), 1996, pp. 27-36
Authors:
ADAMS KF
Citation: Kf. Adams, CURRENT PERSPECTIVES ON BETA-RECEPTOR-ANTAGONISTS IN THE TREATMENT OFSYMPTOMATIC VENTRICULAR DYSFUNCTION, Pharmacotherapy, 16(2), 1996, pp. 69-77
Authors:
SCHULMAN KA
BUXTON M
GLICK H
SCULPHER M
GUZMAN G
KONG J
BACKHOUSE M
MAUSKOPF J
BELL L
EISENBERG JM
CALIFF RM
MCKENNA WJ
HARRELL FE
URETSKY BF
ADAMS KF
SWEDBERG KB
GHEORGHIADE M
ZANNAD F
HANDBERG E
DARIUS H
SOLERSOLER J
WHEELER WS
ARMSTRONG PW
PATTERSON H
MURALI S
BUTMAN S
KIRLIN PC
MILLER LW
JAFRI S
RICH S
COSTANZONORDIN MR
MCGOON M
HOSENPUD JD
RATKOVEC R
BRUNDAGE B
PRITZKER M
BOURGE R
REEVES W
FORGOSH L
VENTURA H
YOUNG JB
MANCINI D
MILLS RM
LIMACHER MC
LEE F
REVKIN J
KALBFLEISCH JM
FISHBEIN D
PRESSLER M
HAEUSSLEIN E
KARLSBERG RP
OCONNELL J
LEJEMTEL TH
THOMAS HM
SMITH WB
MCIVOR M
CINTRON GB
HAGER WD
MESSINEO FC
DOUGHERTY JE
HASSAPOYANNES C
HOOD W
MCGREW F
SANFORD CF
OCONNER CM
HOBBS RE
YARDLEY D
KAY R
MINOTTI J
EASTBURN TE
LINDENFELD J
LITMAN G
WICKEMEYER W
HORTON S
GILBERT EM
EICHORN E
RIBNER HS
CORDER C
PHILBIN E
NOCERO M
ELKAYAM U
JESSUP M
CRAWFORD M
CARSON P
REDDY HK
KLAPHOLZ M
HEYWOOD JT
SALINGER M
KARLSBERG R
BUSH D
HUNTER C
WOHNS D
EISENBERG P
WINSTON S
BUTCHER C
MASSIN E
WYNNE J
TONKON M
SPACCAVENTO L
DIVER D
GHALI J
HUTCHINS S
ANAND I
BEANLANDS D
KOSTUK W
PFLUGFELDER P
LANGLEBEN D
LATOUR P
MIZGALA H
RICCI D
MANYARI D
DARGIE HJ
DAVIDSON C
SWANTON H
HUBNER PJB
OAKLEY D
BROOKS N
JENNINGS K
GREENBAUM RA
PENNY WJ
NICHOLLS P
WALSH M
SUGRUE D
FENNELL W
HORGAN JH
JONDEAU G
CASTAIGNE A
LEMAREC H
WALGER P
PARK JW
DEBERRAZUETA JR
MOL MG
SANCHEZ MAG
CAPONNETTO S
MAGNANI B
GALIE N
DEVITA C
MASERI A
BAGGER JP
REMES J
WALDENSTROM A
SCHAUFELBERGER M
DIENSTI F
SIMOONS ML
KLEIN W
PACHER R
KEOGH A
HARLEY A
Citation: Ka. Schulman et al., RESULTS OF THE ECONOMIC-EVALUATION OF THE FIRST STUDY - A MULTINATIONAL PROSPECTIVE ECONOMIC-EVALUATION, International journal of technology assessment in health care, 12(4), 1996, pp. 698-713
Authors:
MCCARTNEY WH
TSUI BMW
ADAMS KF
LEWIS DP
LALUSH DS
BUJENOVIC LS
LACROIX KJ
JOHNSTON RE
PERRY JR
LONN AHR
MANIAM S
CULP R
Citation: Wh. Mccartney et al., CLINICAL-EVALUATION OF ATTENUATION AND SCATTER COMPENSATION IN TL-201SPECT, The Journal of nuclear medicine, 37(5), 1996, pp. 311-311
Authors:
OCONNOR CM
URETSKY BF
ADAMS KF
MCNULTY SE
GHEORGHIADE M
Citation: Cm. Oconnor et al., INTRAVENOUS DOBUTAMINE IS ASSOCIATED WITH AN INCREASED RISK OF DYING IN ADVANCED CHRONIC HEART-FAILURE - INSIGHTS FROM THE FLOLAN INTERNATIONAL SURVIVAL TRIAL (FIRST), Circulation, 94(8), 1996, pp. 135-135
Authors:
ADAMS KF
SUETA CA
CALIFF RA
GHEORGHIADE M
HARRELL FE
URETSKY B
SWEDBERG K
MCKENNA W
SOLERSOLER J
TOMASKO L
Citation: Kf. Adams et al., GENDER DIFFERENCES IN SURVIVAL IN PATIENTS WITH ADVANCED HEART-FAILURE, Circulation, 94(8), 1996, pp. 1125-1125
Authors:
BRISTOW MR
GILBERT EM
ABRAHAM WT
ADAMS KF
FOWLER MB
HERSHBERGER R
KUBO SH
NARAHARA KA
ROBERTSON AD
KRUEGER S
Citation: Mr. Bristow et al., EFFECT OF CARVEDILOL ON LY FUNCTION AND MORTALITY IN DIABETIC VERSUS NONDIABETIC PATIENTS WITH ISCHEMIC OR NONISCHEMIC DILATED CARDIOMYOPATHY, Circulation, 94(8), 1996, pp. 3879-3879
Authors:
BRISTOW MR
GILBERT EM
ABRAHAM WT
ADAMS KF
FOWLER MB
HERSHBERGER RE
KUBO SH
NARAHARA KA
INGERSOLL H
KRUEGER S
YOUNG S
SHUSTERMAN N
Citation: Mr. Bristow et al., CARVEDILOL PRODUCES DOSE-RELATED IMPROVEMENTS IN LEFT-VENTRICULAR FUNCTION AND SURVIVAL IN SUBJECTS WITH CHRONIC HEART-FAILURE, Circulation, 94(11), 1996, pp. 2807-2816